HOME > TOP STORIES

TOP STORIES

BUSINESS Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later

October 1, 2014
BUSINESS e-Detailing Powerhouse M3 to Establish New Firm Dedicated to CSO Biz

September 30, 2014
BUSINESS Avigan Administered to Ebola-Infected French Woman: Fujifilm

September 29, 2014
ORGANIZATION JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers

September 26, 2014
BUSINESS Takeda to Invest 2.5 Billion Yen in US Firm for New Drug Development

September 26, 2014
BUSINESS AZ Managed to Speed Up Pilot R&D Projects under New Structure: President

September 25, 2014
TRENDS Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018

September 24, 2014
BUSINESS Mediceo Sets to Increase Qualified Reps to 2,000, Enter Contract PMS Biz within 3 Years

September 22, 2014
REGULATORY MHLW Guidelines to Call for Thorough Internal Communications at Pharmas after Novartis’ Delayed ADR Reporting

September 19, 2014
BUSINESS MTPC Generic Arm Seeks to Quickly Broaden Product Lineup, New Alliance a Possibility: Pres.

September 18, 2014
BUSINESS Nippon Shinyaku to Gear Up R&D, Commercialization of Nucleic Acid Products

September 17, 2014
BUSINESS Pharmacy Chains Hurrying to Reach Price Settlements with Wholesalers ahead of Sept.-End Deadline

September 16, 2014
BUSINESS Takara Bio Pushes for Melanoma Drug Development with Eye on Fast Approval

September 12, 2014
REGULATORY Chuikyo’s Drug Pricing Panel to Continue Discussions on Penalties and Actions against Novartis

September 11, 2014
REGULATORY Jichi Medical University President Seen as Prime Candidate for Japan NIH Head

September 10, 2014
ACADEMIA Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study

September 9, 2014
BUSINESS All Eyes Glued to Japan Realignment after Mylan’s Buyout of Abbott’s Established Product Biz

September 8, 2014
BUSINESS MSD’s Januvia Logs 1st Sales Decline in Japan on Re-Pricing

September 5, 2014
BUSINESS US Court Backs Jury Verdict in Actos Suit, Orders Takeda to Pay US$6 Billion in Punitive Damages

September 5, 2014
REGULATORY Industry on Alert as Reformist Shiozaki Tapped as New Health Minister

September 4, 2014

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…

COLUMN

More Positions, More Candidates: A Snapshot of Movement in Japan’s Pharma Industry

By Philip Carrigan

Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…